Pfizer drug linked to heart problems

A new study by researchers at Wake Forest Baptist Medical Center shows that the use of Pfizer’s ChantixTM, a smoking cessation drug, is associated with a 72 percent increased risk of a serious adverse cardiovascular event, such as heart attack or arrhythmia.

Categories: Faculty, For Alumni, For Parents, National, Research, School of Medicine, Top Stories